Physician profile
Ryan C Case
NPI 1891992061
$2,020.35
in general payments reported to CMS, 2019-2025
20 companies · $453 in 2025
The $453 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $172 · 2021: $258 · 2022: $572 · 2023: $157 · 2024: $186 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $761 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.98 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $627.17 | 2020-2025 | Dupixent |
| Allergan, INC. | $333.55 | 2019-2022 | |
| Carestream Dental, LLC | $250.92 | 2022 | |
| Inspire Medical Systems, INC. | $145.69 | 2025 | Inspire |
| Intersect Ent, INC. | $116.04 | 2019-2021 | |
| Smith+Nephew, INC. | $80.36 | 2019-2020 | |
| Genentech USA, INC. | $70.46 | 2019-2020 | |
| Medtronic USA, INC. | $47.76 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $41.78 | 2021-2023 | |
| Medtronic, INC. | $39.62 | 2021 | |
| Genzyme Corporation | $37.79 | 2020 | |
| Sun Pharmaceutical Industries INC. | $36.25 | 2024 | |
| Alk-Abello, INC | $35.46 | 2019-2020 | |
| Amgen INC. | $34.00 | 2025 | |
| Glaxosmithkline, LLC. | $31.01 | 2025 | Nucala |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $24.33 | 2025 | |
| Galderma Laboratories, L.P. | $23.98 | 2020-2023 | |
| Biocryst US Sales Co., LLC | $16.67 | 2022 | |
| Sanofi-Aventis U.S. LLC | $14.94 | 2021 | |
| Kaleo, INC. | $12.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Case listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.